Experimental treatment significantly slowed progression of the fatal brain disease PSP in women
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 22:17 ET (26-Oct-2026 02:17 GMT/UTC)
Researchers at Tel Aviv University have presented new findings indicating that the experimental drug Davunetide may significantly slow the progression of progressive supranuclear palsy (PSP) in women, who exhibited a markedly different response to treatment than men. These results reinforce the need for sex-specific medicine in neurodegenerative diseases.
Announcing a new publication from Opto-Electronic Advances; DOI 10.29026/oea.2026.250334.
A 20-year study of more than 65,000 postmenopausal women found that higher adherence to the Planetary Health Diet was associated with a lower risk of overall cardiovascular disease, coronary heart disease, stroke and heart failure.
In 2021, the FDA issued Phase I voluntary sodium reduction targets to encourage manufacturers to lower the sodium in packaged food products by 2024. The targets appear to have had minimal impact, according to a study comparing sodium content of new products introduced before and after the guidance was issued.